Pre-2017 Archived Letters
Comment Letter to CMS RE: MACRA
Comment letter to U.S. Pharmacopeia (USP) RE: USP Medicare Model Guidelines
Comment letter to Palmetto GBA RE: Down-coding admin codes for biologics
Comment letter to CMS RE: Medicare Part B Prescription Drug Models
Letter to Health Alliance Plan of Michigan RE: Step Therapy Policy
Letter to Regence BlueShield of Washington RE: Step Therapy Policy